Evaluation of SCOUT DS in Subjects With Type 2 Diabetes

NCT01346033 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2012-12-04

No results posted yet for this study

Summary

The primary objective of the trial is to collect SCOUT DS and Hemoglobin A1c measurements of subjects who have been diagnosed with Type 2 diabetes.

Conditions

Sponsors & Collaborators

  • VeraLight, Inc.

    lead INDUSTRY

Principal Investigators

  • Martin L Kabongo, MD,PhD · Accelovance San Diego

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01346033 on ClinicalTrials.gov